导航ENR抑制剂的化学空间:全面分析
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.
Antibiotics (Basel, Switzerland)
|March 27, 2024
概括
这项研究分析了1412种乙烯载体蛋白还原酶 (ENR) 抑制剂,以了解它们的结构特征和生物活性. 计算方法揭示了开发针对耐药细菌的新型抗菌剂的关键决定因素.
科学领域:
- 药用化学 医学化学
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 抗微生物药物耐药性 (AMR) 构成了重大的全球健康挑战,需要新的治疗策略.
- 酸乙烯载体蛋白还原酶 (ENR) 是抗菌药物开发的有效标,但临床成功仍然有限.
- 现有的ENR抑制剂,如三香和异化,突出显示了临床前开发的挑战.
研究的目的:
- 分析ENR抑制剂的大量数据集,以确定生物活性的关键结构决定因素.
- 探索潜在的抗微生物化合物的物理化学特性和结构多样性.
- 利用化学信息学和机器学习来合理设计抗耐药细菌的药物.
主要方法:
- 整理和分析了1412个小分子ENR抑制剂的数据集.
- 采用化学信息工具来绘制物理化学性质并识别生物活性结构特征.
- 使用Lipinski,PAINS和Brenk过器来评估药物相似性.
- 通过化学型多样性,分子相似性,t-SNE,分子复杂性和聚类进行结构多样性分析.
- 应用匹配分子对 (MMP) 分析,机器学习和SHAP分析来理解结构-活动关系.
主要成果:
- 确定了对ENR抑制剂生物活性至关重要的特定结构特征.
- 绘制了分析化合物的物理化学景观.
- 使用已建立过器评估抑制剂的药物相似性和潜在负担.
- 通过先进的计算分析,发现了活动集团和功能组对疗效的影响.
- 证明了集成计算方法在抗微生物药物发现中的实用性.
结论:
- 这种化学信息学研究为FAB抑制剂化学空间提供了宝贵的见解.
- 确定了设计有效ENR抑制剂的关键结构和物理化学决定因素.
- 为合理的抗微生物设计提供了一个框架,整合了用于加速药物发现的计算方法.
更多相关视频
10:20Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
8.5K
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
10.0K
相关概念视频
Enzyme Inhibition
78.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.3K
Enzymes
81.5K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
81.5K
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
